東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

FindBook

Google Book

Amazon

博客來

Implications of V. cholerae Serotypes for Vaccine Development and Infection Outcomes.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Implications of V. cholerae Serotypes for Vaccine Development and Infection Outcomes./
作者:	Fakoya, Bolutife Olurotimi.
面頁冊數:	1 online resource (145 pages)
附註:	Source: Dissertations Abstracts International, Volume: 83-12, Section: B.
Contained By:	Dissertations Abstracts International83-12B.
標題:	Microbiology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=29209073click for full text (PQDT)
ISBN:	9798819381755

Implications of V. cholerae Serotypes for Vaccine Development and Infection Outcomes.
Fakoya, Bolutife Olurotimi.

Implications of V. cholerae Serotypes for Vaccine Development and Infection Outcomes. - 1 online resource (145 pages)

Source: Dissertations Abstracts International, Volume: 83-12, Section: B.

Thesis (Ph.D.)--Harvard University, 2022.

Includes bibliographical references

Vibrio cholerae, the cause of the diarrheal disease cholera, remains a major threat to global public health with approximately 3 million cases reported annually. V. cholerae colonize the human small intestine and possess a range of virulence factors that enable robust colonization of susceptible populations. Cholera vaccines are emerging as important tools for cholera prevention, but different vaccines (depending on their formulations) provide varying levels of protection against the major Ogawa and Inaba serotypes of V. cholerae. Here we describe how we used our knowledge of V. cholerae serotypes to optimize the immunogenicity and crossprotective efficacy of a novel live-attenuated cholera vaccine, refine a murine model of V. cholerae intestinal colonization for evaluating cholera vaccine efficacy, imagine a new paradigm for global cholera challenge studies, and investigate the role that O-antigen modification plays in defining both host and pathogen responses to infection. In summary, we characterize critical translational aspects of cholera vaccine development and elucidate the implications of V. cholerae serotypes on infection outcomes.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2023

Mode of access: World Wide Web

ISBN: 9798819381755Subjects--Topical Terms:

536250
Microbiology.
Subjects--Index Terms:

Cholera vaccineIndex Terms--Genre/Form:

542853
Electronic books.

Implications of V. cholerae Serotypes for Vaccine Development and Infection Outcomes.
LDR:02558nmm a2200409K 4500 001 2359784
005 20230917195245.5
006 m o d
007 cr mn ---uuuuu
008 241011s2022 xx obm 000 0 eng d
020 $a 9798819381755
035 $a (MiAaPQ)AAI29209073
035 $a AAI29209073
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Fakoya, Bolutife Olurotimi. $3 3700400
245 1 0 $a Implications of V. cholerae Serotypes for Vaccine Development and Infection Outcomes.
264 0 $c 2022
300 $a 1 online resource (145 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 83-12, Section: B.
500 $a Advisor: Waldor, Matthew.
502 $a Thesis (Ph.D.)--Harvard University, 2022.
504 $a Includes bibliographical references
520 $a Vibrio cholerae, the cause of the diarrheal disease cholera, remains a major threat to global public health with approximately 3 million cases reported annually. V. cholerae colonize the human small intestine and possess a range of virulence factors that enable robust colonization of susceptible populations. Cholera vaccines are emerging as important tools for cholera prevention, but different vaccines (depending on their formulations) provide varying levels of protection against the major Ogawa and Inaba serotypes of V. cholerae. Here we describe how we used our knowledge of V. cholerae serotypes to optimize the immunogenicity and crossprotective efficacy of a novel live-attenuated cholera vaccine, refine a murine model of V. cholerae intestinal colonization for evaluating cholera vaccine efficacy, imagine a new paradigm for global cholera challenge studies, and investigate the role that O-antigen modification plays in defining both host and pathogen responses to infection. In summary, we characterize critical translational aspects of cholera vaccine development and elucidate the implications of V. cholerae serotypes on infection outcomes.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2023
538 $a Mode of access: World Wide Web
650 4 $a Microbiology. $3 536250
650 4 $a Immunology. $3 611031
650 4 $a Public health. $3 534748
650 4 $a Pharmacology. $3 634543
650 4 $a Molecular biology. $3 517296
653 $a Cholera vaccine
653 $a Immunogenicity
653 $a Crossprotective efficacy
653 $a O-antigen modification
655 7 $a Electronic books. $2 lcsh $3 542853
690 $a 0410
690 $a 0982
690 $a 0573
690 $a 0419
690 $a 0307
710 2 $a ProQuest Information and Learning Co. $3 783688
710 2 $a Harvard University. $b Medical Sciences. $3 3181716
773 0 $t Dissertations Abstracts International $g 83-12B.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=29209073 $z click for full text (PQDT)